DK116871B - Analogifremgangsmåde til fremstilling af terapeutisk virksomme 11β-hydroxypregna-1,4-dien[17&alpha,16α-d]-oxazolin-3,20-dioner. - Google Patents

Analogifremgangsmåde til fremstilling af terapeutisk virksomme 11β-hydroxypregna-1,4-dien[17&alpha,16α-d]-oxazolin-3,20-dioner.

Info

Publication number
DK116871B
DK116871B DK655166AA DK655166A DK116871B DK 116871 B DK116871 B DK 116871B DK 655166A A DK655166A A DK 655166AA DK 655166 A DK655166 A DK 655166A DK 116871 B DK116871 B DK 116871B
Authority
DK
Denmark
Prior art keywords
hydroxypregna
diones
oxazoline
diene
alpha
Prior art date
Application number
DK655166AA
Other languages
Danish (da)
English (en)
Inventor
G Nathansohn
G Winters
E Testa
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of DK116871B publication Critical patent/DK116871B/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036Nitrogen-containing hetero ring
    • C07J71/0057Nitrogen and oxygen
    • C07J71/0068Nitrogen and oxygen at position 16(17)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK655166AA 1966-01-11 1966-12-19 Analogifremgangsmåde til fremstilling af terapeutisk virksomme 11β-hydroxypregna-1,4-dien[17&alpha,16α-d]-oxazolin-3,20-dioner. DK116871B (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1257/66A GB1119081A (en) 1966-01-11 1966-01-11 New steroids
GB3105666 1966-07-11
GB4362866 1966-09-29

Publications (1)

Publication Number Publication Date
DK116871B true DK116871B (da) 1970-02-23

Family

ID=27253862

Family Applications (3)

Application Number Title Priority Date Filing Date
DK655166AA DK116871B (da) 1966-01-11 1966-12-19 Analogifremgangsmåde til fremstilling af terapeutisk virksomme 11β-hydroxypregna-1,4-dien[17&alpha,16α-d]-oxazolin-3,20-dioner.
DK673466AA DK113639B (da) 1966-01-11 1966-12-29 Analogifremgangsmåde til fremstilling af 9α-flour-11β-hydroxypregna-1,4-dien-[17α,16α-d]-oxazolin-3,20-dioner.
DK2767AA DK113640B (da) 1966-01-11 1967-01-03 Analogifremgangsmåde til fremstilling af terapeutisk virksomme 9α,11β-dihalogen-pregna-1,4-dien-[17α,16α-d]-oxazolin-3,20-dioner.

Family Applications After (2)

Application Number Title Priority Date Filing Date
DK673466AA DK113639B (da) 1966-01-11 1966-12-29 Analogifremgangsmåde til fremstilling af 9α-flour-11β-hydroxypregna-1,4-dien-[17α,16α-d]-oxazolin-3,20-dioner.
DK2767AA DK113640B (da) 1966-01-11 1967-01-03 Analogifremgangsmåde til fremstilling af terapeutisk virksomme 9α,11β-dihalogen-pregna-1,4-dien-[17α,16α-d]-oxazolin-3,20-dioner.

Country Status (14)

Country Link
US (2) US3624077A (US20030157376A1-20030821-M00001.png)
AT (3) AT269384B (US20030157376A1-20030821-M00001.png)
BE (3) BE692434A (US20030157376A1-20030821-M00001.png)
BR (3) BR6685836D0 (US20030157376A1-20030821-M00001.png)
CH (3) CH468370A (US20030157376A1-20030821-M00001.png)
DE (2) DE1568971C3 (US20030157376A1-20030821-M00001.png)
DK (3) DK116871B (US20030157376A1-20030821-M00001.png)
ES (3) ES335489A1 (US20030157376A1-20030821-M00001.png)
FR (4) FR1509315A (US20030157376A1-20030821-M00001.png)
GB (1) GB1119081A (US20030157376A1-20030821-M00001.png)
IL (3) IL27027A (US20030157376A1-20030821-M00001.png)
NL (3) NL6700108A (US20030157376A1-20030821-M00001.png)
NO (3) NO127347B (US20030157376A1-20030821-M00001.png)
SE (3) SE328283B (US20030157376A1-20030821-M00001.png)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1141930B (it) * 1980-04-28 1986-10-08 Lepetit Spa Esteri idrosolubili di steroido-ossazoli e loro composizioni farmaceutiche

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2838499A (en) * 1957-11-29 1958-06-10 Upjohn Co 6-fluoro steroids and process
US2838498A (en) * 1957-11-29 1958-06-10 Upjohn Co 6-fluoro-delta4-3-keto steroids and process for preparing same
NL128816C (US20030157376A1-20030821-M00001.png) * 1965-04-22

Also Published As

Publication number Publication date
CH468370A (fr) 1969-02-15
CH468994A (fr) 1969-02-28
SE328283B (US20030157376A1-20030821-M00001.png) 1970-09-14
BR6685838D0 (pt) 1973-12-27
GB1119081A (en) 1968-07-10
BR6685836D0 (pt) 1973-12-27
US3461119A (en) 1969-08-12
DE1568971A1 (de) 1970-06-18
IL27027A (en) 1971-02-25
DE1568972A1 (de) 1970-06-18
FR1509314A (fr) 1968-01-12
AT269383B (de) 1969-03-10
DE1618613C3 (de) 1974-04-25
NL6700157A (US20030157376A1-20030821-M00001.png) 1967-07-12
DE1618613A1 (de) 1971-01-14
ES335490A1 (es) 1967-12-01
NL139967B (nl) 1973-10-15
DE1618613B2 (de) 1973-09-13
SE330885B (US20030157376A1-20030821-M00001.png) 1970-12-07
BR6685837D0 (pt) 1973-12-27
BE692434A (US20030157376A1-20030821-M00001.png) 1967-06-16
BE692432A (US20030157376A1-20030821-M00001.png) 1967-06-16
SE330884B (US20030157376A1-20030821-M00001.png) 1970-12-07
BE692433A (US20030157376A1-20030821-M00001.png) 1967-06-16
DE1568971C3 (de) 1974-03-14
NO127669B (US20030157376A1-20030821-M00001.png) 1973-07-30
AT269384B (de) 1969-03-10
FR1509316A (fr) 1968-01-12
NO127668B (US20030157376A1-20030821-M00001.png) 1973-07-30
AT268561B (de) 1969-02-10
DK113640B (da) 1969-04-14
DK113639B (da) 1969-04-14
FR1509315A (fr) 1968-01-12
NL6700108A (US20030157376A1-20030821-M00001.png) 1967-07-12
IL27028A (en) 1971-03-24
US3624077A (en) 1971-11-30
ES335489A1 (es) 1967-12-01
FR6765M (US20030157376A1-20030821-M00001.png) 1969-03-10
DE1568971B2 (de) 1973-08-16
IL27075A (en) 1971-01-28
CH468993A (fr) 1969-02-28
NO127347B (US20030157376A1-20030821-M00001.png) 1973-06-12
NL6700431A (US20030157376A1-20030821-M00001.png) 1967-07-12
ES335491A1 (es) 1967-12-01

Similar Documents

Publication Publication Date Title
DK128353B (da) Analogifremgangsmåde til fremstilling af terapeutisk aktive bis-chromoner.
DK116205B (da) Analogifremgangsmåde til fremstilling af 17α-alkanoyloxy-9α-halogen-16β-methyl-11β,21-dihydroxy-Δ<1,4>-pregnadien-3,20-dioner.
FI49497C (fi) Menetelmä terapeuttisesti vaikuttavien 1-fenoksi-2-3-alkyyliaminopropa anien valmistamiseksi.
FI50707C (fi) Menetelmä uusien farmakologisesti vaikuttavien hydroksisykloheksyyliam iinien valmistamiseksi.
FI49720C (fi) Menetelmä terapeuttisesti vaikuttavien 2-metyyli-3-karbonihappoamidoki noksaliini-di-N-oksidien-(1,4) valmistamiseksi.
DK119557B (da) Analogifremgangsmåde til fremstilling af 17α-benzoyloxy-9α-fluor-16β-methyl-Δ<1,4>-pregnadien-11β, 21-diol-3,20-dion.
DK118877B (da) Analogifremgangsmåde til fremstilling af 3,1-benzoxazin-2-oner.
DK120190B (da) Analogifremgangsmåde til fremstilling af terapeutisk aktive 17-estere af 9α,11β-dihalogen-16α-alkyl-Δ<1,4>-pregnadien-17α,21-diol-3,20-dioner.
DK117635B (da) Analogifremgangsmåde til fremstilling af terapeutisk virksomme 3-(piperazinoalkyl)-pyrazoler.
FI49718C (fi) Menetelmä terapeuttisesti vaikuttavien 2-halogeenimetyyli-3-karbonihap poamidokinoksaliini-di-N-oksidien-(1,4) valmistamiseksi.
DK115617B (da) Fremgangsmåde til fremstilling af 2,2-dichlor-1,1,3,3-tetrafluorpropan.
DK122760B (da) Analogifremgangsmåde til fremstilling af terapeutisk virksomme 4-alkoxy-3,5-dimethoxybenzamider.
DK116871B (da) Analogifremgangsmåde til fremstilling af terapeutisk virksomme 11β-hydroxypregna-1,4-dien[17&alpha,16α-d]-oxazolin-3,20-dioner.
DK118557B (da) Fremgangsmåde til fremstilling af 17α-acyloxy-11β-hydroxy-Δ<4>-pregnen-3,20-dioner.
DK112235B (da) Fremgangsmåde til fremstilling af terapeutisk virksomme 21-dicyclohexylmethylcarbonater af 21-hydroxy-Δ<4>-pregnen-17α-ol-3,20-dioner.
DK116658B (da) Fremgangsmåde til fremstilling af terapeutisk aktive 7α-methyl-Δ<5>-østrener.
DK124882B (da) Analogifremgangsmåde til fremstilling af 17α-acyloxy-11β-methyl-19-norpregn-4-en-3,20-dioner.
DK121510B (da) Fremgangsmåde til fremstilling af terapeutisk aktive 7α-methyl-Δ<5(10)>-østrener.
DK122763B (da) Analogifremgangsmåde til fremstilling af terapeutisk aktive 1,2α-methylen-4-pregnen-3,20-dionderivater.
DK126937B (da) Fremgangsmåde til fremstilling af 4,6-dihalogen-16-alkyliden-17α-hydroxy-pregna-4,6-dien-3,20-dioner.
FI43994C (fi) Menetelmä uusien terapeuttisesti vaikuttavien 1,2-diaryyli-4-alkyyli-3,5-diokso-pyratsolidiinien valmistamiseksi
FI46066C (fi) Analogiamenetelmä terapeuttisesti vaikuttavien N,N-dimetyyliamino-etyy li-14beta-hydroksi-5beta-pregn-20-eeni-21-karboksylaattien valmistamis eksi.
DK124822B (da) Analogifremgangsmåde til fremstilling af terapeutisk virksomme 16α-thiosubstituerede 9β, 10α-pregn-4-en-3,20-dioner.
DK122223B (da) Analogifremgangsmåde til fremstilling af terapeutisk aktive biphenylforbindelser.
DK117897B (da) Fremgangsmåde til fremstilling af terapeutisk virksomme 21-trialkylsiloxypregnan-3,20-dioner.

Legal Events

Date Code Title Description
PUP Patent expired